💬In plain words
What the trial is, and whether it could suit you
Lipedema is a chronic condition that mainly affects women and causes abnormal fat accumulation, pain, heaviness, tenderness, swelling, and difficulty with movement, especially in the lower limbs. Liposuction is sometimes used to reduce the abnormal fatty tissue in people with lower-limb lipedema. However, after surgery, patients may still experience swelling, pain, bruising, tissue stiffness, and reduced mobility during recovery.
Physiotherapy is an important part of recovery after liposuction for lipedema. It may include compression therapy, manual lymphatic drainage, gentle exercises, walking, skin care, and patient education. These treatments aim to reduce swelling, improve circulation, support tissue healing, and help patients return to daily activities.
This study will investigate whether adding Endermologie to a standard physiotherapy program can improve recovery after liposuctio
Sign in to get the eligibility rules as simple questions to take to your doctor.
📋 Eligibility rules (as published)
Inclusion Criteria:
Participants will be eligible for inclusion if they meet all of the following criteria:
Female participants diagnosed with lower-limb lipedema. Age between 25 and 45 years old.
* Clinical diagnosis of lipedema confirmed by the treating physician or specialist physiotherapist.
* Lipedema stage II or stage III based on clinical presentation, including disproportionate fat deposition, pain/tenderness, easy bruising, tissue nodularity, or lobular tissue changes.
* Scheduled for or recently underwent lower-limb liposuction for lipedema management.
* Body mass index (BMI) between 25 and 35 kg/m².
* Medically stable and cleared by the treating surgeon to start postoperative physiotherapy.
* Ability to understand instructions and comply with treatment visits and assessment procedures.
* Willingness to wear prescribed compression garments according to the postoperative protocol.
3.2 Exclusion Criteria
* Primary or secondary lymphedema unrelated to lipedema, unless clearly differentiated and documented.
* Lipedema stage IV with advanced lipo-lymphedema requiring complex decongestive therapy beyond the study protocol.
* BMI greater than 35 kg/m² or less than 25 kg/m².
* Uncontrolled diabetes mellitus, uncontrolled hypertension, severe cardiovascular disease, renal disease, hepatic disease, or active systemic inflammatory disease.
* Deep vein thrombosis, active thrombophlebitis, severe peripheral arterial disease, or untreated varicose complications.
* Active infection, open wounds, skin ulceration, cellulitis, or significant postoperative complications preventing mechanical therapy.
* Known coagulopathy, current anticoagulation therapy not cleared by the surgeon, or high bleeding risk.
* Pregnancy or lactation.
* Previous lower-limb liposuction within the preceding 12 months.
* Use of other structured edema-reduction interventions during the study period outside the assigned protocol.
* Inability to attend scheduled follow-up assessments.
HealthTeky